Search

Displaying results 7131 - 7140 of 7452 in total
  1. Drug

    XR5944

    go.drugbank.com/drugs/DB06364
    Experimental

    XR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.

  2. Drug

    Evernimicin

    go.drugbank.com/drugs/DB06431
    Experimental

  3. Drug

    Tecastemizole

    go.drugbank.com/drugs/DB06457
    Experimental

  4. Drug

    Liatermin

    go.drugbank.com/drugs/DB06489
    Investigational

  5. Drug

    L523S

    go.drugbank.com/drugs/DB06498
    Investigational

    According to Nemunaitis J., et al, "L523S is an immunogenic lung cancer antigen that has demonstrated preclinical safety when the gene is injected intramuscularly as an expressive plasmid (pVAX/L523S) and when delivered following incorpo...

  6. Drug

    Siramesine

    go.drugbank.com/drugs/DB06555
    Experimental

  7. Drug

    alpha-Hydroxy glycineamide

    go.drugbank.com/drugs/DB06568
    Experimental

    Alpha-hydroxy glycineamide (αHGA) is the active antiviral metabolite of tri-peptide glycyl-prolyl-glycine-amide (GPG-NH2). αHGA inhibits the replication of HIV-1 in vitro by interfering with the capsid formation. It also has an effect on...

  8. Drug

    Baminercept

    go.drugbank.com/drugs/DB06576
    Investigational

  9. Drug

    7-beta-Hydroxyepiandrosterone

    go.drugbank.com/drugs/DB06622
    Investigational

  10. Drug

    EHT899

    go.drugbank.com/drugs/DB05108
    Experimental

    EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It also apparently enhances a secondary immune response to clear the viral infection, result...